Sanofi's focus: Experimental medicines
November 19, 2014 at 12:24 PM EST
After drug company Sanofi removed CEO Chris Viehbacher, investors question the future of the company's growth and future.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|